Abstract: A measuring system is described which includes a sensor for receiving an electromagnetic wave and a guide component for guiding the electromagnetic wave. The guide component is embodied as an elongated, preferably metal, profile component which contains, in a longitudinal direction, a slot for guiding the electromagnetic wave.

Abstract: The present invention relates to a process for the catalytic oxidation of sulphide, mono- and/or dihydrogen sulphide, comprising the step of contacting the sulphide, mono- and/or dihydrogen sulphide in the presence of oxygen with a chelate complex comprising (i) a metal cation selected from the group consisting of Fez+, Mnz+, NiZ+ and Coz+, where z=2 or 3, and (ii) a chelate ligand containing a porphyrin, a phthalocyanine or a porphyrazine ring coordinated to the metal cation, and at least one cationic substituent covalently attached to the ring in the chelate ligand.

Abstract: A detection device for detecting a blood count parameter in a blood vessel, comprising a transmitter having a number of transmit antennas for transmitting at least one transmit signal, a receiver having a number of receive antennas for receiving at least one receive signal, a processor to select a detection configuration comprising one of the transmit antennas and one of the receive antennas and select a second detection configuration comprising one of the transmit antennas and one of the receive antennas, and a loss detector that is designed, when the first detection configuration is selected to transmit a transmit signal, to detect a first loss value on the basis of the transmit signal and a receive signal, and, when the second detection configuration is selected to transmit a transmit signal, detect a second loss value on the basis of the transmit signal and a receive signal. The processor is designed to select the detection configuration having the lower loss value to detect the blood count parameter.

Abstract: The present invention is directed to a microarray for the detection of an angiostatic tumor stage/tumor area of colorectal carcinoma in a patient, wherein the microarray comprises gene probes capable of specifically hybridizing to predefined nucleic acids. The invention is further directed to an inhibitor or modulator of one or more of these nucleic acids, as well as to a pharmaceutical composition, comprising those inhibitors or modulators. In a further aspect, the present invention is directed to an ex vivo method for the diagnosis of an angiostatic tumor stage/tumor area in a patient suffering from a colorectal carcinoma. In a further aspect the invention is directed to predict the response of patients with colorectal carcinoma but also other diseases to therapy.

Abstract: The invention relates to nucleic acid molecules encoding peptides which interact with autoantibodies associated with glaucoma, to the peptides themselves, to a pharmaceutical composition comprising said nucleic acid molecules and peptides, and to the use of said peptides—especially in apheresis—for the treatment of glaucoma.